News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
78 Results
Type
Company Profile (1)
Press Release (77)
Section
Business (23)
Deals (2)
Drug Development (4)
Job Trends (12)
News (29)
Tag
Alliances (2)
Best Places to Work (13)
Biotechnology (1)
Clinical research (10)
Compensation (3)
Data (4)
Duchenne muscular dystrophy (6)
Earnings (18)
Events (20)
Executive appointments (1)
Funding (1)
IPO (3)
NextGen: Class of 2026 (1)
People (12)
Phase 1 (10)
Phase 2 (5)
Pipeline (3)
Regulatory (1)
Date
Last 30 days (2)
Last 365 days (17)
2026 (5)
2025 (15)
2024 (15)
2023 (17)
2022 (13)
2021 (6)
2020 (3)
2019 (3)
2018 (1)
Location
Massachusetts (27)
United States (27)
78 Results for "entradatx".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Entrada Therapeutics to Present at Upcoming Investor Conferences - February 4, 2026
February 4, 2026
·
1 min read
Press Releases
Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - March 2, 2026
March 3, 2026
·
1 min read
Press Releases
Entrada Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
December 17, 2025
·
1 min read
Press Releases
Independent Data Monitoring Committee Recommends Initiation of Cohort 2 at the Increased Dose of 12 mg/kg in Entrada Therapeutics’ ELEVATE-44-201 Study
February 17, 2026
·
6 min read
Press Releases
Entrada Therapeutics to Present at Upcoming Investor Conferences - October 28, 2025
October 28, 2025
·
1 min read
Press Releases
Entrada Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results
February 26, 2026
·
12 min read
Press Releases
Entrada Therapeutics Highlights Progress Across its Portfolio of RNA-based Therapeutics for the Treatment of Neuromuscular and Ocular Diseases
January 8, 2026
·
11 min read
Press Releases
Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - December 4, 2025
December 5, 2025
·
2 min read
Press Releases
Entrada Therapeutics Announces Recipients of Third Annual DREAMS Grant Program
September 8, 2025
·
4 min read
Press Releases
Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - September 2, 2025
September 3, 2025
·
2 min read
1 of 8
Next
